• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ROCHE OMNI S; BLOOD GAS ANALYZER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ROCHE OMNI S; BLOOD GAS ANALYZER Back to Search Results
Catalog Number 03337154001
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/13/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(6).(b)(4).
 
Event Description
The customer stated that they received questionable low results for an unspecified number of patient samples tested for partial pressure of oxygen (po2) on the cobas b 221<6>=roche omni s6 system (b221) in the critical care unit.The customer provided data for five patient samples that had erroneous po2 results.Erroneous results are reported outside of the laboratory.Po2 was the only test parameter that was affected.All samples were initially tested on the b221 analyzer and the po2 results were low.The samples were repeated on a second b221 analyzer used in the laboratory.The fifth patient sample was tested after deproteinizer and system reagents were changed on both analyzers.Samples are injected into the analyzer and they make sure there is no air in them.The lot number and expiration date of the po2 electrode/cartridge was asked for, but not provided.The field service engineer checked the analyzer.He ran a patient sample comparison after checking the analyzer.
 
Manufacturer Narrative
No medical treatment was changed based on the po2 result.No adverse events were alleged.The electrode had been changed on (b)(6) 2018.On (b)(6) 2018, the field service engineer completed preventive maintenance on the analyzer.All affected patients were on varying degrees of oxygen while samples were collected for testing.
 
Manufacturer Narrative
The higher po2 results measured on the second cobas b221 could be partially due to the delay between measurements.These delays in measurement were between 12 and 31 minutes later.Also the effect of sample transport from the ward to the laboratory cannot be excluded.No details about the transport could be provided.No other influence could be determined.Calibration and qc were acceptable.The investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ROCHE OMNI S
Type of Device
BLOOD GAS ANALYZER
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key7309151
MDR Text Key101700928
Report Number1823260-2018-00630
Device Sequence Number1
Product Code CHL
Combination Product (y/n)N
PMA/PMN Number
K032311
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup,Followup
Report Date 09/13/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number03337154001
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 02/13/2018
Initial Date FDA Received03/02/2018
Supplement Dates Manufacturer Received02/13/2018
02/13/2018
02/13/2018
Supplement Dates FDA Received03/27/2018
04/04/2018
09/13/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-